trial · primary record
Oral Brepocitinib
Cutaneous Sarcoidosis
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 168 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Part 1: Number of participants with Treatment Emergent Adverse Events and Serious Adverse Events as assessed by CTCAE v5.0 |
| Registry ID | NCT06978725 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:49.217Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06978725
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.